Penumbra, Inc. (PEN) financial statements and ratios from SEC XBRL: revenue $1.40B (TTM), net margin 12.7%, revenue growth 17.5% YoY, P/E 87.5. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $1.40B |
| Net Margin | 12.7% |
| Revenue Growth (YoY) | 17.5% |
| EPS Growth (YoY) | 1169.4% |
| FCF Growth (YoY) | 18.8% |
| P/E Ratio | 87.5 |
| EV / EBITDA | 63.2 |
| Price / Book | 8.34 |
| Price / Sales | 8.54 |
| FCF Yield | 2.8% |
| DCF Value (model) | $81.08 |
| DCF Upside vs Price | -75.0% |
| Altman Z-Score | 21.09 (safe) |
| Sector P/E (Healthcare) | 21.6 |
PEN overview · PEN earnings · PEN KPIs · PEN investor relations · PEN ownership · PEN peers · PEN filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.